PreciseDx Funding: $32M Raised, Series B (2024)

PreciseDx is based in New York, NY. It has raised $32M in total funding. Latest round: Series B.

PreciseDx funding overview

PreciseDx is based in New York, NY. PreciseDx has raised $32M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in August 2024. The round record for PreciseDx runs through 2024; nothing later has been disclosed. Investors on record include Eventide Asset Management, Merck Global Health Innovation Fund, Philips Ventures, Labcorp, Quest Diagnostics, GenHenn Capital Venture. 6 distinct backers are named across the disclosed rounds.

PreciseDx at a glance

Total raised
$32M
Latest round
Series B
Latest round date
August 2024
Headquarters
New York, NY
Notable investors
Eventide Asset Management, Merck Global Health Innovation Fund, Philips Ventures, Labcorp, Quest Diagnostics, GenHenn Capital Venture

Frequently asked about PreciseDx funding

How much has PreciseDx raised?
PreciseDx has raised $32M in total disclosed funding across the rounds on record.
Who has invested in PreciseDx?
Eventide Asset Management, Merck Global Health Innovation Fund, Philips Ventures, Labcorp, Quest Diagnostics, GenHenn Capital Venture are named among the investors backing PreciseDx.
What was the latest PreciseDx funding round?
The most recent disclosed round is a Series B, announced in August 2024.
Where is PreciseDx based?
PreciseDx is based in New York, NY.
When did PreciseDx last raise?
The last disclosed PreciseDx round closed in August 2024 at Series B.

Every PreciseDx figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in New York at a similar stage.

Companies related to PreciseDx (33)

Browse related funding lists (7)

Company funding database · Investor directory · Founder database · Mega-rounds 2026